期刊文献+

表柔比星联合环磷酰胺治疗方案对乳腺癌术后患者的疗效分析 被引量:4

下载PDF
导出
摘要 乳腺癌属于女性群体较常见的一种恶性肿瘤,其发病率仅次于子宫癌,主要发生于乳腺导管上皮组织,早期乳腺癌通常无典型症状与体征,患者也不易引起重视,一般是通过健康体检或乳腺癌筛查时被发现[1,2]。大部分乳腺癌患者确诊时已属于中晚期,失去最佳治疗时机[3]。现阶段,临床对于乳腺癌主要采用手术、化疗等方法治疗,乳腺癌改良根治术是近年来较常用的术式,但临床在乳腺癌术后化疗方案的选择上至今尚无统一定论[4]。
作者 邢晶莹
出处 《山西医药杂志》 CAS 2021年第1期70-72,共3页 Shanxi Medical Journal
  • 相关文献

参考文献11

二级参考文献92

  • 1杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1504
  • 2鲍云华,李俭杰.介绍新的实体瘤治疗反应评价标准(RECIST)[J].中国肺癌杂志,2005,8(1):77-78. 被引量:109
  • 3Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer[J]. N Engl J Med,2010,363(20) :1938-1948.
  • 4Carey LA,Dees EC,Sawyer L, et al. The triple negative para-dox: primary tumor chemosensitivity of breast cancer subtypes[J]. Clin Cancer Res,2007,13(8) :2329-2334.
  • 5Iwata H, Sato N, Masuda N, et al. Docetaxel followed by flu-orouracil/epirubicin/cyclophosphamide as neoadjuvant chemo-therapy for patients with primary breast cancer[J]. Jpn J ClinOncol,2011,41(7) :867-875.
  • 6Warm M, Kates R, Grobe-Onnebrink E, et al. Impact of tumorbiology,particularly triple-negative status,on response to preop-erative sequential, dose-dense epirubicin, cyclophosphamide fol-lowed by docetaxel in breast cancer[J]. Anti cancer Res, 2010,30(10):4251-4259.
  • 7Torrisi R.Balduzzi A’Ghisini R, et al. Tailored preoperative treat-ment of locally advanced triple negative (hormone receptor negativeand Her-2 negative) breast cancer with epirubicin, cisplatin.and infu-sional fluorouracil followed by weekly paclitaxel [J]. Cancer Che-mother Pharmacol,2008,62(4) :667-672.
  • 8Eisenhauer EA, Therasse P, Bogaerts J, et al. New response e-valuation criteria in solid tumours: revised RECIST guideline(version 1. 1) [J]. Eur J Cancer,2009,45(2) :228-247.
  • 9Huober J,von Minckwitz G,Denkert C et al. Effect of neoadju-vant anthracycline taxane-based chemotherapy in different bio-logical breast cancer phenotypes : overall results from the Gepar-Trio study[J]. Breast Cancer Res Treat,2010,124(1) : 133-140.
  • 10Wu J, Li S’Jia W, et al. Response and prognosis of taxanes andanthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer[J]. J Cancer Res Clin Oncol, 2011, 137(10)=1505-1510.

共引文献186

同被引文献53

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部